📈 Price History

Ratio Health

— Excellent

— Good

— Average

— Poor

By Category

📊 Peer Medians

About

Nomad Foods Limited, together with its subsidiaries, manufactures, markets, and distributes a range of frozen food products in the United Kingdom and internationally. The company offers frozen fish products, including fish fingers, coated fish, and natural fish; ready-to-cook vegetable products, such as peas and spinach; and frozen poultry and meat products, comprising nuggets, grills, and burgers. It also provides meal products that contain ready-to-cook noodles, pasta, lasagna, pancakes, and other ready-made meals; ice creams, such as in-home and out-of-home ice creams; and other products comprising soups, pizzas, bakery goods, and meat substitutes. The company sells its products to supermarkets and food retail chains primarily under the Birds Eye, Green Cuisine, iglo, Findus, Aunt Bessie's, Goodfella's, Frikom, Ledo, La Cocinera, and Belviva brand names. Nomad Foods Limited was founded in 2014 and is headquartered in Woking, the United Kingdom.

Key Ratios Snapshot

📈 Growth Pattern

⚡ Latest Quarter —

See full financials →

📊 Quick Scorecard

Loading…

📊 MIXED Nomad Foods Q1 2026: organic sales -5.3%, adj. EBITDA -23%, EPS EUR0.23

Revenue & Profitability

First quarter organic revenue declined 5.3% year-on-year. Adjusted EBITDA fell 23% to an undisclosed absolute amount. Adjusted EPS was EUR 0.23, down EUR 0.12 from prior year. The company repurchased EUR 24 million of shares and ended the quarter with EUR 283 million of cash. Adjusted free cash flow conversion was 36%.

Outlook

Management views the frozen food category as healthy, with 3.8% category growth in Q1, accelerating from 2% last quarter. They expect full-year organic revenue to decline 2%-5% and constant currency adjusted EBITDA to decline 5%-10%. Q2 is expected to be below full-year targets due to AMP rephasing and residual price negotiation impacts, with stronger second-half results anticipated.

Growth Drivers

Growth levers include expanding beyond core categories and geographies, removing self-imposed nutrition constraints in categories like pizza, and restructuring marketing to reinvest behind consumers and brands. Geographies with positive growth in Q1 included Italy, Austria, Portugal, Sweden, Switzerland (low single-digit), Norway (high single-digit), and Croatia (mid-teens). A new analyst day is planned for fall 2026.

Balance Sheet & CapEx

Not discussed in this earnings call.

Margins

Gross margin declined 210 basis points in Q1 due to partial price benefit and ongoing cost inflation. Price and productivity are expected to contribute positively to gross margin for the remainder of the year. Adjusted EBITDA declined 23% in Q1, and full-year guidance calls for a 5%-10% decline at constant currency. Adjusted free cash flow conversion is expected to be 90% or greater for the full year.

Key Risks

Management flagged risks from cost inflation, price negotiation disruptions with retailers, and inventory destocking following price increases. The change in order patterns to better align sell-in with sell-out also created a temporary headwind. These disruptions were anticipated and are now considered behind the company. Share-based payment expenses, exceptional items, and foreign currency translation are also noted as adjustments.

Generated by AI · Q1 2026 results · Not investment advice

✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter

🔍

🔎 See cross-company document search → ?

📞 Earnings Call Transcripts (5)

Q2 2026 Q2 2026 [Q&A] 2026-08-13

Retail disruptions have been resolved, supporting improved performance in the second half. Gross margin growth is driven by pricing and productivity, with some one-time benefits expected to reverse. Leadership changes and a comprehensive value plan aim to boost competitiveness.

Q1 2026 Q1 2026 [Q&A] 2026-05-07

Q1 2026 delivered stronger-than-expected growth at 3.8%, despite temporary disruptions from price negotiations in key markets. Inflation remains manageable, with profitability expected to improve in H2, and the company is shifting to a more flexible portfolio strategy.

Q4 2025 Q4 2025 [Q&A] 2026-02-26

2026 is expected to be a transition year with negative net sales due to pricing negotiations and fish cost inflation, but management remains confident in long-term growth, planning share purchases and continued investment in innovation and retail execution.

Q3 2025 Q3 2025 [Q&A] 2025-11-06

Medium-term efficiency and EBITDA growth targets remain intact, with most pricing actions deferred to Q1 2026 and a focus on cost savings and product renovation. Q4 guidance is reiterated at the low end, and capital allocation will prioritize share buybacks amid increased liquidity.

Q2 2025 Q2 2025 (Q&A) 2025-08-06

Guidance was revised lower due to ERP and inventory issues, with weather and inflation further impacting results. Market share gains and cost savings were achieved, while innovation and portfolio diversification are expected to drive future growth.

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯

Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.

📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.